NUS

Nu Skin Enterprises, Inc. Consumer Defensive - Household & Personal Products Investor Relations →

YES
61.5% BELOW
↑ Moving away Was -61.5% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $18.47
14-Week RSI 29 📉
Rel. Volume (14w) This week's trading vs. the 14-week average 1.6x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.82

Nu Skin Enterprises, Inc. (NUS) closed at $7.12 as of 2026-03-20, trading 61.5% below its 200-week moving average of $18.47. This places NUS in the extreme value zone. The stock moved further from the line this week, up from -61.5% last week. With a 14-week RSI of 29, NUS is in oversold territory.

Trading volume is running at 1.6x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.82 ratio) is neutral — neither side is clearly dominating.

Over the past 1482 weeks of data, NUS has crossed below its 200-week moving average 27 times. On average, these episodes lasted 29 weeks. Historically, investors who bought NUS at the start of these episodes saw an average one-year return of +5.4%.

With a market cap of $343 million, NUS is a small-cap stock. The company generates a free cash flow yield of 26.5%, which is notably high. Return on equity stands at 22.0%, indicating strong profitability. The stock trades at 0.4x book value.

Management has been repurchasing shares, with a 2.6% reduction over three years. NUS passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.

Over the past 28.5 years, a hypothetical investment of $100 in NUS would have grown to $75, compared to $1153 for the S&P 500. NUS has returned -1.0% annualized vs 9.0% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: NUS vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After NUS Crosses Below the Line?

Across 27 historical episodes, buying NUS when it crossed below its 200-week moving average produced an average return of +1.1% after 12 months (median -6.0%), compared to +9.8% for the S&P 500 over the same periods. 33% of those episodes were profitable after one year. After 24 months, the average return was +4.3% vs +18.1% for the index.

Each line shows $100 invested at the moment NUS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

NUS has crossed below its 200-week MA 27 times with an average 1-year return of +5.4% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Oct 1997Mar 19982135.1%-2.0%-25.4%
Jun 1998Nov 19982353.2%-8.0%-30.9%
Dec 1998Dec 199813.6%-60.3%-36.0%
Feb 1999Apr 200216573.5%-55.9%-36.7%
Jul 2002Aug 2002219.9%+27.2%+58.5%
Mar 2003Mar 200311.8%+140.9%+47.3%
Apr 2003Apr 200310.6%+189.2%+49.6%
Apr 2006Sep 20062020.1%+2.5%-25.8%
Sep 2006Oct 200621.8%-0.2%-27.9%
Jan 2007Mar 20086025.1%-14.0%-31.5%
Mar 2008Mar 200811.2%-40.1%-33.7%
Apr 2008Jun 20096045.2%-25.0%-33.4%
Jul 2009Jul 200910.1%+84.9%-24.1%
Aug 2014Mar 20153229.2%+1.4%-78.2%
May 2015Aug 20166548.8%-22.9%-80.2%
Oct 2016May 20172613.6%+15.6%-82.0%
May 2017May 201710.3%+49.4%-82.6%
Mar 2019Sep 20208063.9%-58.2%-81.5%
Oct 2020Nov 202045.1%-16.3%-82.6%
Dec 2020Dec 202010.2%-7.0%-83.5%
Feb 2021Mar 202136.5%+5.5%-82.5%
Apr 2021Apr 202110.2%-1.2%-83.6%
Aug 2021Dec 20211920.6%-8.8%-83.7%
Feb 2022Mar 202254.8%-10.8%-82.5%
Apr 2022Aug 20221610.2%-5.3%-81.9%
Aug 2022Jan 20232224.3%-41.5%-80.7%
Feb 2023Ongoing161+81.0%Ongoing-80.4%
Average29+5.4%

Frequently Asked Questions

Is NUS below its 200-week moving average?

Yes. As of 2026-03-20, Nu Skin Enterprises, Inc. (NUS) is trading 61.5% below its 200-week moving average of $18.47. The current price is $7.12.

What is NUS's 200-week moving average price?

Nu Skin Enterprises, Inc.'s 200-week moving average is $18.47 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when NUS drops below its 200-week moving average?

NUS has crossed below its 200-week moving average 27 times in our data. On average, buying at that moment produced a one-year return of +5.4%. These dips have historically been decent entry points. These episodes lasted 29 weeks on average.

Is NUS a good value right now?

Here's what our data says about NUS as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 29 (oversold). Free cash flow yield is 26.5%. Return on equity is 22.0%. Price-to-book is 0.4x. This is not a buy or sell recommendation — always do your own research.

How does NUS compare to the S&P 500?

Over the past 28.5 years, $100 invested in NUS would have grown to $75, compared to $1153 for the S&P 500. That's -1.0% annualized vs 9.0% for the index. NUS has underperformed the broader market over this period.

Does NUS pay a dividend?

Yes. Nu Skin Enterprises, Inc. currently pays a dividend yield of 337.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-03-20